NORTH READING, Mass., March 21, 2017 /PRNewswire/ -- TraceLink Inc., the World's Largest Track and Trace Network forconnecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced that the Pharmacy at Trillium Health selected the TraceLink Life Sciences Cloud to comply with the U.S. Drug Supply
Trillium Health, headquartered in Rochester, New York, was formed in 2010 as a result of the merger of AIDS Community Health Center and AIDS Rochester, to provide integrated, personalized primary and specialty medical care to people from diverse communities. Trillium Health extends services and programs into the community through education, support, and direct access to treatment with onsite pharmacies.
The World Health Organization estimates that between 1% and 10% of drugs sold around the world are counterfeit, with that number reaching as high as 50% in some countries. In 2013, DSCSA was signed into U.S. law to combat counterfeit drugs and ensure patient safety by enabling verification of pharmaceutical products, improving the detection of suspect ones, and facilitating product recalls. By 2020, all hospital, retail and individual pharmacies must comply with DSCSA serialization regulations, only buying or selling prescription drug products with a unique product identifier on each package.
"As a provider of affordable, accessible and quality health care for our community, we fully support DSCSA and are committed to ensuring the delivery of safe medicine to our patients," said Mark J. Malahosky, R.Ph., BPharm, Vice President of Pharmacy Services at Trillium Health. "In order to prepare for the upcoming serialization regulations for pharmacies, we chose TraceLink's solution to enable us to cost-effectively comply with DSCSA and connect directly to our wholesale partners."
"The DSCSA law introduces complexities for health systems and pharmacies right out of the gate and requires an increasingly digital state over time for hospitals and health networks. Trillium's dedication to delivering comprehensive primary and specialty care, in parallel with TraceLink's own mission of protecting patients and enabling quality health care, forms a shared vision that ensures compliance and patient safety," said Shabbir Dahod, president and CEO, TraceLink. "We look forward to working with Trillium Health and assisting them with safeguarding their daily pharmacy operations, allowing their healthcare providers to continue their patient-centric mission."
TraceLink's Product Track solution provides end to end compliance with U.S. Drug Supply Chain Security Act (DSCSA) tracing and verification regulations for hospitals, pharmacies and health networks. To learn more about how TraceLink can protect pharmacy operations, easily help meet DSCSA requirements and enable a direct connection with thousands of suppliers on the Life Sciences Cloud network, visit http://www.tracelink.com.
About TraceLink TraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 149 in 2016), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.
TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/trillium-health-selects-tracelink-to-protect-its-pharmaceutical-operations-and-ensure-patient-safety-300426977.html
Subscribe to our Free Newsletters!
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...
Find out about travel shots or vaccination before you travel to your destination country. Travel ...
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...View All